Cargando…
Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
Abstract. Background: H(1) antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-ol...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040003/ https://www.ncbi.nlm.nih.gov/pubmed/30402619 http://dx.doi.org/10.5414/ALX01554E |
_version_ | 1783338780548136960 |
---|---|
author | Durda, J. Wedi, B. Martin, V. Breuer, K. |
author_facet | Durda, J. Wedi, B. Martin, V. Breuer, K. |
author_sort | Durda, J. |
collection | PubMed |
description | Abstract. Background: H(1) antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-old female patient suffering from chronic spontaneous urticaria who experienced severe episodes of wheals and flares induced by different H(1) antihistamines. Methods: We performed skin prick tests (SPT) with a diversity of H(1) antihistamines and CAST and FlowCAST analyses. Moreover, a placebo controlled oral challenge test to mizolastin was done. Results: We saw positive SPT reactions to nearly all H(1) antihistamines tested with the exception of mizolastin. We observed neither a release of sulfidoleukotrienes nor an upregulation of basophil activation markers in the CAST and FlowCAST analyses. The oral challenge test with mizolastine resulted in the development of generalized wheals and flares. Conclusion: H(1) antihistamines are effective drugs for the treatment of urticaria, but they may lead to hypersensitivity reactions in rare cases. Because of the negative CAST and FlowCAST results, an IgE-mediated pathomechanism is improbable. We propose that hypersensitivity reactions to H(1) antihistamines may be induced by a paradox H(1) receptor activation. |
format | Online Article Text |
id | pubmed-6040003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dustri-Verlag Dr. Karl Feistle |
record_format | MEDLINE/PubMed |
spelling | pubmed-60400032018-11-06 Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria Durda, J. Wedi, B. Martin, V. Breuer, K. Allergol Select Case Report Abstract. Background: H(1) antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-old female patient suffering from chronic spontaneous urticaria who experienced severe episodes of wheals and flares induced by different H(1) antihistamines. Methods: We performed skin prick tests (SPT) with a diversity of H(1) antihistamines and CAST and FlowCAST analyses. Moreover, a placebo controlled oral challenge test to mizolastin was done. Results: We saw positive SPT reactions to nearly all H(1) antihistamines tested with the exception of mizolastin. We observed neither a release of sulfidoleukotrienes nor an upregulation of basophil activation markers in the CAST and FlowCAST analyses. The oral challenge test with mizolastine resulted in the development of generalized wheals and flares. Conclusion: H(1) antihistamines are effective drugs for the treatment of urticaria, but they may lead to hypersensitivity reactions in rare cases. Because of the negative CAST and FlowCAST results, an IgE-mediated pathomechanism is improbable. We propose that hypersensitivity reactions to H(1) antihistamines may be induced by a paradox H(1) receptor activation. Dustri-Verlag Dr. Karl Feistle 2017-08-04 /pmc/articles/PMC6040003/ /pubmed/30402619 http://dx.doi.org/10.5414/ALX01554E Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Durda, J. Wedi, B. Martin, V. Breuer, K. Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
title | Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
title_full | Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
title_fullStr | Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
title_full_unstemmed | Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
title_short | Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
title_sort | hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040003/ https://www.ncbi.nlm.nih.gov/pubmed/30402619 http://dx.doi.org/10.5414/ALX01554E |
work_keys_str_mv | AT durdaj hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria AT wedib hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria AT martinv hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria AT breuerk hyperresponsivenesstoantihistaminesinspontaneousurticariaandheaturticaria |